All Xrays

Tab : Impact of new laws on cancer treatment during pregnancy

Most relevant for: People who have cancer who are pregnant.

The U.S. Supreme Court ruled in 2022 that abortion is no longer a protected right under the Constitution.  This landmark decision leaves regulation of abortion to the states. Cancer treatment during pregnancy may now be impacted in states that have abortion bans or limitations. (Posted 5/31/23)

Article : A food lover’s decision to remove her stomach highlights difficult decisions around cancer risk

Most relevant for: People with a CDH1 mutation or a family history of stomach cancer.

National Public Radio reporter Sáša Woodruff shares her story of learning about her CDH1 mutation and making a decision about risk-reducing surgery. Mutations in the CDH1 gene significantly increase a person’s risk of stomach and breast cancers. Woodruff’s personal essay describes the psychological challenge of making decisions about risk-reducing surgeries and draws attention to a lesser-known mutation linked to hereditary cancer. (Posted 5/17/23)

Study : Early removal of ovaries may be linked to small increase in risk of Parkinson’s disease in later life

Most relevant for: Women considering risk-reducing removal of both ovaries

The lifetime risk of developing Parkinson’s disease is low. However, having surgery to remove both ovaries before natural menopause can slightly increase the risk of Parkinson's disease later in life. Researchers studied over 20 years of medical records, which confirmed this small increase in risk, particularly for women who have their ovaries removed before age 43. (Posted 5/3/23)

Este artículo está disponible en español.

Study : Hormonal birth control may reduce ovarian cancer risk in people with BRCA mutations

Most relevant for: Women with BRCA1 or BRCA2 mutations who are interested in reducing their ovarian cancer risk.

Hormonal birth control pill is linked to reduced ovarian cancer among people with an inherited BRCA mutation. Longer-acting forms of birth control given by implant, injection or as an intrauterine device may be associated with lower ovarian cancer risk for people with an inherited BRCA mutation. (Posted 4/28/23)

Este artículo está disponible en español.

Study : Hair straightening products linked to small increased risk of endometrial cancer

Most relevant for: People who use hair straightening products.

Many people use products to straighten their hair. Use of these products, especially frequent use, is linked to a small increase in endometrial cancer.  (Posted 4/18/23)

Este artículo está disponible en español.

Study : Breast cancer outcomes improved with CDK4/6 inhibitor treatment

Most relevant for: People with HR-positive HER2-negative advanced breast cancer

A study showed that people with HR-positive, HER2-negative metastatic breast cancer who took an oral drug known as a CDK4/6 inhibitor combined with hormone therapy fared better than people who took hormone therapy alone. The drug combination improved progression-free survival (the length of time before cancer worsened or returned). After six years of treatment, overall survival was also better for those who took this drug combination compared to those who took hormone therapy alone. Posted (4/5/23)

Este artículo está disponible en español.

Study : Weight may affect breast cancer risk in women with an inherited BRCA mutation

Most relevant for: People with an inherited mutation in BRCA1 or BRCA2 concerned about their breast cancer risk

A study that looked at normal breast cells from women with an inherited BRCA mutation found more DNA damage among women who were overweight (based on a measurement known as body mass index) than those who were not overweight. The results suggest that maintaining a lower weight may reduce breast cancer among this high-risk population. (Posted 3/30/23)

Este artículo está disponible en español.

Study : New oral drug treatment for some advanced breast cancer

Most relevant for: People with HR-positive, HER2-negative advanced breast cancer

The FDA has approved a new oral drug for the treatment of HR-positive, HER2-negative advanced breast cancer. A companion blood test was also approved to help doctors identify patients who would benefit most from this new treatment. (Posted 3/20/23)

Este artículo está disponible en español.

Study : Systemic racism may delay breast biopsy for Black and Asian people

Most relevant for: People who have had an abnormal mammogram

Black and Asian people are more likely to have to wait more than 90 days between an abnormal mammogram and a biopsy compared to white people. After accounting for other factors, the authors conclude that these disparities may be due to systemic racism. (Posted 3/8/23)

Este artículo está disponible en español.

Study : Promising early results for treating metastatic prostate cancer

Most relevant for: People with metastatic castration-resistant prostate cancer (mCRP)

The TALAPRO studies looked at how well the oral PARP inhibitor talazoparib (Talzenna) works as a treatment for metastatic castration-resistant prostate cancer (mCRPC). Research has shown that the addition of talazoparib to treatment with enzalutamide (Xtandi) improved progression-free survival. However, the greatest benefit was seen in people who had an inherited or tumor mutation in a gene that repairs DNA damage (such as ATM, BRCA1, BRCA2 and others). (Posted 3/1/23)

Este artículo está disponible en español.